NFKBIA and glioblastoma: The deletion of NFKBIA (encoding nuclear factor of κ-light polypeptide gene enhancer in B-cells inhibitor-α), an inhibitor of the EGFR-signaling pathway, is reported to promote tumor development in GBM, which does not show mutations of EGFR [12].